The impact of genome wide supported microRNA-137 (MIR137) risk variants on frontal and striatal white matter integrity, neurocognitive functioning, and negative symptoms in schizophrenia

The miR-137 schizophrenia susceptibility variant rs1625579 does not predict variability in brain volume in a sample of schizophrenic patients and healthy individuals

(2014) Emma J. Rose et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS

Negative symptoms of schizophrenia: Clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment

(2014) Mark J. Millan et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Frontostriatal activity and connectivity increase during proactive inhibition across adolescence and early adulthood

(2014) Matthijs Vink et al.   HUMAN BRAIN MAPPING

miR-137: A New Player in Schizophrenia

(2014) Jingwen Yin et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

MicroRNA-137 regulates a glucocorticoid receptor–dependent signalling network: implications for the etiology of schizophrenia

(2014) Astrid Vallès et al.   JOURNAL OF PSYCHIATRY & NEUROSCIENCE

The Impact of MIR137 on Dorsolateral Prefrontal–Hippocampal Functional Connectivity in Healthy Subjects

(2014) Bing Liu et al.   NEUROPSYCHOPHARMACOLOGY

Genome-wide schizophrenia variant at MIR137 does not impact white matter microstructure in healthy participants

(2014) Sinead Kelly et al.   NEUROSCIENCE LETTERS

No effect of schizophrenia risk genes MIR137, TCF4, and ZNF804A on macroscopic brain structure

(2014) Helena Cousijn et al.   SCHIZOPHRENIA RESEARCH

Transcriptional consequences of schizophrenia candidate miR-137 manipulation in human neural progenitor cells

(2014) Matthew J. Hill et al.   SCHIZOPHRENIA RESEARCH

Dysfunction and Dysconnection in Cortical–Striatal Networks during Sustained Attention: Genetic Risk for Schizophrenia or Bipolar Disorder and its Impact on Brain Network Function

(2014) Vaibhav A. Diwadkar et al.   Frontiers in Psychiatry

Methamphetamine-Induced Disruption of Frontostriatal Reward Learning Signals: Relation to Psychotic Symptoms

(2013) Javier Bernacer et al.   AMERICAN JOURNAL OF PSYCHIATRY

Schizophrenia miR-137 Locus Risk Genotype Is Associated with Dorsolateral Prefrontal Cortex Hyperactivation

(2013) Theo G.M. van Erp et al.   BIOLOGICAL PSYCHIATRY

Analysis of miR-137 expression and rs1625579 in dorsolateral prefrontal cortex

(2013) Ilaria Guella et al.   JOURNAL OF PSYCHIATRIC RESEARCH

The genome-wide supported microRNA-137 variant predicts phenotypic heterogeneity within schizophrenia

(2013) T A Lett et al.   MOLECULAR PSYCHIATRY

Genome-wide association analysis identifies 13 new risk loci for schizophrenia

(2013) Stephan Ripke et al.   NATURE GENETICS

Effects of MIR137 on fronto-amygdala functional connectivity

(2013) Omar Mothersill et al.   NEUROIMAGE

Impact of the genome-wide schizophrenia risk single nucleotide polymorphism (rs1625579) in miR-137 on brain structures in healthy individuals

(2013) Ming Li et al.   PSYCHIATRIC GENETICS

MIR137 gene and target gene CACNA1C of miR-137 contribute to schizophrenia susceptibility in Han Chinese

(2013) Fanglin Guan et al.   SCHIZOPHRENIA RESEARCH

Functional Dysconnectivity of Corticostriatal Circuitry as a Risk Phenotype for Psychosis

(2013) Alex Fornito et al.   JAMA Psychiatry

From the Prodrome to Chronic Schizophrenia: The Neurobiology Underlying Psychotic Symptoms and Cognitive Impairments

(2012) O. D. Howes et al.   CURRENT PHARMACEUTICAL DESIGN

Genome-wide supported variant MIR137 and severe negative symptoms predict membership of an impaired cognitive subtype of schizophrenia

(2012) M J Green et al.   MOLECULAR PSYCHIATRY

Impact of a microRNA MIR137 Susceptibility Variant on Brain Function in People at High Genetic Risk of Schizophrenia or Bipolar Disorder

(2012) Heather C Whalley et al.   NEUROPSYCHOPHARMACOLOGY

Mood congruent psychotic symptoms and specific cognitive deficits in carriers of the novel schizophrenia risk variant at MIR-137

(2012) E. Cummings et al.   NEUROSCIENCE LETTERS

Experimental validation of candidate schizophrenia gene ZNF804A as target for hsa-miR-137

(2012) Albert H. Kim et al.   SCHIZOPHRENIA RESEARCH

Chromosome 1p21.3 microdeletions comprising DPYD and MIR137 are associated with intellectual disability

(2011) M. H. Willemsen et al.   JOURNAL OF MEDICAL GENETICS

Validation of schizophrenia-associated genes CSMD1, C10orf26, CACNA1C and TCF4 as miR-137 targets

(2011) E Kwon et al.   MOLECULAR PSYCHIATRY

Genome-wide association study identifies five new schizophrenia loci

(2011)   NATURE GENETICS

Cross talk between microRNA and epigenetic regulation in adult neurogenesis

(2010) Keith E. Szulwach et al.   JOURNAL OF CELL BIOLOGY

MicroRNA miR-137 Regulates Neuronal Maturation by Targeting Ubiquitin Ligase Mind Bomb-1

(2010) Richard D. Smrt et al.   STEM CELLS